FDA Pulmonary Division acting director
Executive Summary
Badrul Chowdhury, MD/PhD, appointed acting director of FDA's CDER Division of Pulmonary & Allergy Drug Products. Chowdhury, a team leader in the division for three years and a member of the Clarinex review team, succeeds Robert Meyer, MD, who became Office of Drug Evaluation II director in June (1"The Pink Sheet" June 3, p. 9)...